1 (800) 463-1008 (Canada) or (908) 852-2311 (USA)

October 2013

I-MED Approvals By Health Canada

I-MED Pharma Inc., a Montreal-based biotechnology company and Biocia Inc., a New Jersey-based biotechnology company announced today the Health Canada approval for their fourth generation preservative-free, multi-dose, viscoadaptive eye drop, I-Drop® PUR Gel for treating Ocular Surface Disorder (OSD) such as dry eye disease (DED). This product already received a CE mark earlier this year.

Read more